Literature DB >> 31685971

Treatment choices for newly diagnosed primary open angle and ocular hypertension patients.

Anurag Garg1, Gus Gazzard2.   

Abstract

Despite advances in our knowledge of the aetiology and pathophysiology of glaucoma, the sole proven, effective intervention for treating primary open-angle glaucoma (POAG) and ocular hypertension (OHT) remains lowering of intraocular pressure (IOP) to prevent further progression and visual loss. The purpose of this review is to evaluate the treatment choices available to newly diagnosed POAG and OHT patients. We review the existing literature on treatments currently available to newly diagnosed POAG and OHT patients and discuss their role in the treatment paradigm of POAG and OHT. We consider different factors that may be important when offering a choice of treatment to newly diagnosed POAG and OHT patients as well as describing new glaucoma treatments in development and future directions for treatment.

Entities:  

Mesh:

Year:  2019        PMID: 31685971      PMCID: PMC7002706          DOI: 10.1038/s41433-019-0633-6

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  34 in total

1.  [Practical manual of blood transfusion in operation rooms and intensive care units].

Authors:  I Narita
Journal:  Rinsho Byori       Date:  1991-03

2.  [Methylprednisolone improves prognosis in traumatic spinal cord injuries].

Authors:  G Sundbärg
Journal:  Lakartidningen       Date:  1991-07-10

3.  The response to distension of the pulmonary vein-left atrial junctions in dogs with spinal section.

Authors:  S M Burkhart; J R Ledsome
Journal:  J Physiol       Date:  1974-03       Impact factor: 5.182

4.  Valium induction.

Authors:  M A Costello
Journal:  J Am Assoc Nurse Anesth       Date:  1971-06

5.  Rho-dependence of the terminator active at the end of the I region of transcription of bacteriophage f1.

Authors:  M La Farina; M Vitale
Journal:  Mol Gen Genet       Date:  1984

6.  Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.

Authors:  C B Toris; C B Camras; M E Yablonski
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

Review 7.  Histology and fine structure of the iris and outflow system following latanoprost therapy.

Authors:  Ian Grierson; Norbert Pfeiffer; Kathryn P B Cracknell; Paul Appleton
Journal:  Surv Ophthalmol       Date:  2002-08       Impact factor: 6.048

Review 8.  Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.

Authors:  Tianjing Li; Kristina Lindsley; Benjamin Rouse; Hwanhee Hong; Qiyuan Shi; David S Friedman; Richard Wormald; Kay Dickersin
Journal:  Ophthalmology       Date:  2015-10-31       Impact factor: 12.079

9.  Antibody against low density lipoprotein receptor blocks uptake of low density lipoprotein (but not high density lipoprotein) by the adrenal gland of the mouse in vivo.

Authors:  T Kita; U Beisiegel; J L Goldstein; W J Schneider; M S Brown
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

10.  Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines.

Authors:  Bruce E Prum; Lisa F Rosenberg; Steven J Gedde; Steven L Mansberger; Joshua D Stein; Sayoko E Moroi; Leon W Herndon; Michele C Lim; Ruth D Williams
Journal:  Ophthalmology       Date:  2015-11-12       Impact factor: 12.079

View more
  1 in total

1.  ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma.

Authors:  Kavita Praveen; Gaurang C Patel; Lauren Gurski; Ariane H Ayer; Trikaladarshi Persaud; Matthew D Still; Lawrence Miloscio; Tavé Van Zyl; Silvio Alessandro Di Gioia; Ben Brumpton; Kristi Krebs; Bjørn Olav Åsvold; Esteban Chen; Venkata R M Chavali; Wen Fury; Harini V Gudiseva; Sarah Hyde; Eric Jorgenson; Stephanie Lefebvre; Dadong Li; Alexander Li; James Mclninch; Brijeshkumar Patel; Jeremy S Rabinowitz; Rebecca Salowe; Claudia Schurmann; Anne-Sofie Seidelin; Eli Stahl; Dylan Sun; Tanya M Teslovich; Anne Tybjærg-Hansen; Cristen Willer; Scott Waldron; Sabrina Walley; Hua Yang; Sarthak Zaveri; Ying Hu; Kristian Hveem; Olle Melander; Lili Milani; Stefan Stender; Joan M O'Brien; Marcus B Jones; Gonçalo R Abecasis; Michael N Cantor; Jonathan Weyne; Katia Karalis; Aris Economides; Giusy Della Gatta; Manuel A Ferreira; George D Yancopoulos; Aris Baras; Carmelo Romano; Giovanni Coppola
Journal:  Commun Biol       Date:  2022-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.